Back to Search
MATTHEW VERRILL, MD
MD
Family Medicine Physician
NPI: 1326242611IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
2009-02094(NC)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
TOLEDO MEDICAL COLLEGE
Class of 2007
Research & Publications (20)
Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial.
PMID 19447249·Lancet·2009
3-trial
Development and validation of cell-based ELISA for the quantification of trastuzumab in human plasma.
PMID 19376123·J Immunol Methods·2009
4-observational
Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring.
PMID 19259090·Br J Cancer·2009
6-review
Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk.
PMID 19153118·Ann Oncol·2009
6-review
Phase II genomics study of ixabepilone as neoadjuvant treatment for breast cancer.
PMID 19075286·J Clin Oncol·2009
3-trial
A phase I and pharmacokinetic study of ixabepilone in combination with Carboplatin in patients with advanced solid malignancies.
PMID 19088046·Clin Cancer Res·2008
3-trial
Introduction to sessions on 'Optimizing the implementation of future treatments--time to abandon traditional methods'.
PMID 19128435·Breast Cancer Res·2008
8-other
Hormonal therapy for postmenopausal breast cancer: the science of sequencing.
PMID 17039263·Breast Cancer Res Treat·2007
6-review
A randomized, double-blind, phase II study of two doses of pemetrexed as first-line chemotherapy for advanced breast cancer.
PMID 17575230·Clin Cancer Res·2007
3-trial
TEXAS (Taxotere EXperience with Anthracyclines Study) trial: mature results of activity/toxicity of docetaxel given with anthracyclines in a community setting, as first line therapy for MBC.
PMID 17009036·Cancer Chemother Pharmacol·2007
3-trial
A phase I and pharmacokinetic study of paclitaxel poliglumex (XYOTAX), investigating both 3-weekly and 2-weekly schedules.
PMID 16278406·Clin Cancer Res·2005
3-trial
An investigation into the psychometric properties of the Hospital Anxiety and Depression Scale in patients with breast cancer.
PMID 16018801·Health Qual Life Outcomes·2005
4-observational
Neoadjuvant vinorelbine/epirubicin (VE) versus standard adriamycin/cyclophosphamide (AC) in operable breast cancer: analysis of response and tolerability in a randomised phase III trial (TOPIC 2).
PMID 15946977·Ann Oncol·2005
3-trial
Vinorelbine alternating oral and intravenous plus epirubicin in first-line therapy of metastatic breast cancer: results of a multicentre phase II study.
PMID 15928659·Br J Cancer·2005
3-trial
Mitomycin C, vinblastine and cisplatin (MVP): an active and well-tolerated salvage regimen for advanced breast cancer.
PMID 15685237·Br J Cancer·2005
3-trial
Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial.
PMID 15265969·J Natl Cancer Inst·2004
3-trial
Phase I study of carboplatin, doxorubicin and weekly paclitaxel in patients with advanced ovarian carcinoma.
PMID 12649113·Ann Oncol·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2700 S PROVIDENCE RD, STE 300
WAXHAW, NC 28173 - Phone
- (704) 243-2254
Quick Facts
- NPI
- 1326242611
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 19
- Publications
- 20
Are you this provider?
Claim Your Profile